市場調查報告書
商品編碼
1425147
高流量針組市場 – 2024 年至 2029 年預測High Flow Needle Sets Market - Forecasts from 2024 to 2029 |
2022 年,高流量針套市值為 7.8965 億美元,預計在預測期內複合年成長率為 5.64%。
高流量針頭組是專為確保使用者安全和舒適而設計的針頭組。這種類型的針用於將更黏稠的藥物注射到體內。高流量針頭組比標準針頭更舒適快速。慢性病的增加和醫療保健技術的進步是支持高流量針組市場顯著成長的關鍵驅動力。
市場促進因素
慢性病的流行是高流量針組市場的關鍵促進因素。癌症、心血管疾病和出血性疾病的發生率正在上升,這些疾病通常需要頻繁的藥物和輸液,因此需要使用高流量針頭套件。例如,根據世界衛生組織(WHO)統計,非傳染性疾病每年導致4100萬人死亡,佔全球總死亡人數的74%,其中77%因非傳染性疾病死亡。- 收入國家。
醫療保健技術的進步在提高安全性、準確性和相容性的高流量針頭套件的開發中發揮了關鍵作用。這為高流量針頭套件的開發鋪平了道路,以提高患者的舒適度和安全性。由於製造商持續關注技術創新,市場顯著成長。例如,2023年1月,科爾醫療系統公司與一家製藥公司提案了一項皮下免疫球蛋白療法(SCIg)的開發協議,尋求建立並核准帶有SCIg預充式預填充式注射器的Freedom Infusion System。這有利於患者在家中的藥物輸送。
技術進步在擴大高流量注射器針頭組市場方面發揮重要作用。許多國家正在投資加強其醫療基礎設施,導致對高流量針頭等先進醫療設備的需求增加。此外,慢性病發病率較高的人口不斷成長,以及對高流量針組益處的認知不斷提高,也推動了這種擴張。例如,2021 年 10 月,印度政府啟動了 Pradhan Mantri Ayushman Bharat 衛生基礎設施任務。該計畫宣布,截至 25-26 會計年度預計支出為 6,418 億盧比。這是該國最大的泛印度計劃,旨在改善醫療基礎設施,也增加了對高低針組等醫療設備的需求。
預計北美將主導市場
由於該地區主要國家的高醫療保健標準和各種慢性病的盛行率不斷上升,預計北美將佔據重要的市場佔有率。美國政府正在投資醫療基礎設施和醫療產品,顯著增加了對高流量針組的需求。例如,國家醫療支出帳戶追蹤美國每年在醫療保健商品和服務、政府營運和醫療保健投資方面的支出。 2021年,美國醫療保健支出將成長2.7%,達到4.3兆美元,即人均12,914美元。醫療衛生支出佔國內生產總值的18.3%。
市場挑戰
高流量針組市場的成長可能會受到針刺傷害和醫療中心醫護人員的安全疑慮的限制。針刺傷危及在醫療過程中使用高流量針組的醫護人員的生命。這些損傷會傳播血液傳播的病原體,例如愛滋病毒、B型肝炎和C型肝炎。醫護人員的健康和福祉對於醫療保健系統的整體運作至關重要。
公司產品
The high-flow needle sets market was valued at US$789.65 million in 2022 and is expected to grow at a CAGR of 5.64% during the forecast period.
High-flow needle sets are needle sets that are created to ensure user safety and comfort. While administering more viscous drugs to the body, these types of needles are used. High-flow needle sets are more comfortable and faster than standard needles. Growing chronic disease prevalence, and healthcare technology advancement have emerged as a significant driving force behind the substantial growth of the high-flow needle sets market.
Market Drivers
Chronic disease prevalence is a significant driver of the high-flow needle set market. Cancer, cardiovascular disease, and bleeding disorders are on the rise, and these conditions usually require frequent medication or fluid withdrawal, which requires the use of high-flow needle sets. For instance, according to the World Health Organization, non-communicable diseases kill 41 million people per year, accounting for 74% of the total deaths worldwide, and 77% of non-communicable disease deaths occur in low- and middle-income countries.
Advances in healthcare technology have played a vital role in the development of high-flow needle sets with improved safety, preciseness, and compatibility. It established the way for the development of high-flow needle sets that support patient comfort and security. The market has grown significantly fueled by the manufacturer's ongoing focus on innovation. For instance, in January 2023, KORU Medical Systems proposed a development agreement with the pharmaceutical company of subcutaneous immunoglobulin therapy (SCIg) to establish and seek approval for a Freedom Infusion System with a SCIg prefilled syringe. This will make the subcutaneous delivery of drugs easier for patients at home.
Technology advancements play a vital role in high-flow needle sets market expansion. Many countries are making investments to enhance their healthcare infrastructure, which led to an increase in demand for advanced medical equipment such as high-flow needle sets. This expansion is fueled additionally by the growing population, which is more likely to suffer from chronic diseases, as well as increased awareness of the benefits of high-flow needle sets. For instance, in October 2021, the Government of India launched the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission. This scheme was announced with an estimated outlay of Rs. 64,180 Cr until FY 25-26. It is the country's largest pan-India scheme for improving healthcare infrastructure as well as the increase in demand for medical equipment such as high-low needle sets.
North America is anticipated to dominate the market
North America will account for a considerable market share owing to the high medical standards and increased prevalence of various chronic diseases in the region's major economies. The U.S. government is investing in healthcare infrastructures and healthcare goods which substantially increases the demand for high-flow needle sets. For instance, National Health Expenditure Accounts tracks annual U.S. spending on healthcare goods and services, government operations, and health-care investment. In 2021, healthcare spending in the United States will increase by 2.7 percent to $4.3 trillion, or $12,914 per person. Health spending accounted for 18.3 percent of the nation's Gross Domestic Product.
Market Challenges
The growth of the high-flow needle sets market may be restrained by needlestick injuries and safety concerns for healthcare workers in medical centers. Needlestick injuries endanger the lives of healthcare workers who use high-flow needle sets during medical procedures. These injuries have a chance to spread bloodborne pathogens such as HIV, hepatitis B, and hepatitis C. The health and well-being of healthcare workers are critical to the overall operation of healthcare systems.
Market Development
Company Products
Segmentation